Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Cerebrovascular Disorders

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 83 articles:
HTML format
Text format



Single Articles


    May 2019
  1. DIENER HC, Sacco RL, Easton JD, Granger CB, et al
    Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
    N Engl J Med. 2019;380:1906-1917.
    PubMed     Text format     Abstract available


  2. MARSHALL RS
    Image-Guided Intravenous Alteplase for Stroke - Shattering a Time Window.
    N Engl J Med. 2019;380:1865-1866.
    PubMed     Text format    


  3. MA H, Campbell BCV, Parsons MW, Churilov L, et al
    Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke.
    N Engl J Med. 2019;380:1795-1803.
    PubMed     Text format     Abstract available


    April 2019
  4. MEHRA MR, Uriel N, Naka Y, Cleveland JC Jr, et al
    A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.
    N Engl J Med. 2019;380:1618-1627.
    PubMed     Text format     Abstract available


  5. OMBRELLO AK, Qin J, Hoffmann PM, Kumar P, et al
    Treatment Strategies for Deficiency of Adenosine Deaminase 2.
    N Engl J Med. 2019;380:1582-1584.
    PubMed     Text format    


  6. NGUYEN G, Feigin V, Roth G
    Lifetime Risk of Stroke in the Global Burden of Disease Study. Reply.
    N Engl J Med. 2019;380:1378.
    PubMed     Text format    


  7. ZHAO HL, Huang Y
    Lifetime Risk of Stroke in the Global Burden of Disease Study.
    N Engl J Med. 2019;380:1377-1378.
    PubMed     Text format    


  8. LIU F, Huang K, Lu X
    Lifetime Risk of Stroke in the Global Burden of Disease Study.
    N Engl J Med. 2019;380:1377.
    PubMed     Text format    


  9. CONNOLLY SJ, Crowther M, Eikelboom JW, Gibson CM, et al
    Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.
    N Engl J Med. 2019;380:1326-1335.
    PubMed     Text format     Abstract available


    March 2019
  10. SCHUCHT P, Fischer U, Fung C, Bernasconi C, et al
    Follow-up Computed Tomography after Evacuation of Chronic Subdural Hematoma.
    N Engl J Med. 2019;380:1186-1187.
    PubMed     Text format    


  11. MACK MJ, Leon MB, Thourani VH, Makkar R, et al
    Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMoa1814052.
    PubMed     Text format     Abstract available


  12. POPMA JJ, Deeb GM, Yakubov SJ, Mumtaz M, et al
    Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMoa1816885.
    PubMed     Text format     Abstract available


    February 2019
  13. RIDKER PM, Everett BM, Pradhan A, MacFadyen JG, et al
    Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
    N Engl J Med. 2019;380:752-762.
    PubMed     Text format     Abstract available


    January 2019
  14. TAGGART DP, Benedetto U, Gerry S, Altman DG, et al
    Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years.
    N Engl J Med. 2019;380:437-446.
    PubMed     Text format     Abstract available


    December 2018
  15. FEIGIN VL, Nguyen G, Cercy K, Johnson CO, et al
    Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016.
    N Engl J Med. 2018;379:2429-2437.
    PubMed     Text format     Abstract available


    November 2018
  16. PRASAD S, Young LH, Bouffard M, Gupta R, et al
    Case 37-2018: A 23-Year-Old Woman with Vision Loss.
    N Engl J Med. 2018;379:2152-2159.
    PubMed     Text format    


  17. PROVENZANO AM
    Becoming a Caregiver - Lessons from My Dad.
    N Engl J Med. 2018;379:1696-1697.
    PubMed     Text format    


    October 2018
  18. YIN X, Wang D
    Antiplatelet Agents in Acute Stroke and TIA.
    N Engl J Med. 2018;379:e29.
    PubMed     Text format    


  19. JIA L, Ji H, Li R
    Antiplatelet Agents in Acute Stroke and TIA.
    N Engl J Med. 2018;379:e29.
    PubMed     Text format    



  20. Antiplatelet Agents in Acute Stroke and TIA.
    N Engl J Med. 2018;379:e29.
    PubMed     Text format    



  21. Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke.
    N Engl J Med. 2018;379:1579-1581.
    PubMed     Text format    


  22. WUSSLER D, du Fay de Lavallaz J, Mueller C
    Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke.
    N Engl J Med. 2018;379:1580.
    PubMed     Text format    


  23. YIN X, Wang D
    Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke.
    N Engl J Med. 2018;379:1579-1580.
    PubMed     Text format    


    September 2018
  24. HARLOFF A, Schlachetzki F
    Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
    N Engl J Med. 2018;379:986-7.
    PubMed     Text format    


  25. SU Q, Li Q
    Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
    N Engl J Med. 2018;379:986.
    PubMed     Text format    


  26. GIRGIS M, Jelaidan I
    Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
    N Engl J Med. 2018;379:986.
    PubMed     Text format    



  27. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
    N Engl J Med. 2018;379:986-987.
    PubMed     Text format    


    August 2018
  28. ZANNAD F, Anker SD, Byra WM, Cleland JGF, et al
    Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.
    N Engl J Med. 2018 Aug 27. doi: 10.1056/NEJMoa1808848.
    PubMed     Text format     Abstract available


  29. MAZER CD, Whitlock RP, Fergusson DA, Belley-Cote E, et al
    Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808561.
    PubMed     Text format     Abstract available


  30. RAWSHANI A, Rawshani A, Franzen S, Sattar N, et al
    Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2018;379:633-644.
    PubMed     Text format     Abstract available


    July 2018
  31. TAYLOR JB, Prager LM, Quijije NV, Schaefer PW, et al
    Case 21-2018: A 61-Year-Old Man with Grandiosity, Impulsivity, and Decreased Sleep.
    N Engl J Med. 2018;379:182-189.
    PubMed     Text format    


    June 2018
  32. TRUFFAUT L, Lefebvre P
    Tongue Necrosis in Giant-Cell Arteritis.
    N Engl J Med. 2018;378:2517.
    PubMed     Text format    



  33. High-Dose Atorvastatin after Stroke or Transient Ischemic Attack.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMx180019.
    PubMed     Text format    


    May 2018
  34. HART RG, Sharma M, Mundl H, Kasner SE, et al
    Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1802686.
    PubMed     Text format     Abstract available


  35. AMARENCO P, Lavallee PC, Monteiro Tavares L, Labreuche J, et al
    Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1802712.
    PubMed     Text format     Abstract available


  36. THOMALLA G, Simonsen CZ, Boutitie F, Andersen G, et al
    MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1804355.
    PubMed     Text format     Abstract available


  37. GROTTA JC
    Antiplatelet Therapy after Ischemic Stroke or TIA.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMe1806043.
    PubMed     Text format    


  38. JOVIN TG
    MRI-Guided Intravenous Alteplase for Stroke - Still Stuck in Time.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMe1805796.
    PubMed     Text format    


  39. JOHNSTON SC, Easton JD, Farrant M, Barsan W, et al
    Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1800410.
    PubMed     Text format     Abstract available


  40. VINNY PW, Vishnu VY, Srivastava MVP
    Thrombectomy for Stroke with Selection by Perfusion Imaging.
    N Engl J Med. 2018;378:1849.
    PubMed     Text format    



  41. Thrombectomy for Stroke with Selection by Perfusion Imaging.
    N Engl J Med. 2018;378:1849-1850.
    PubMed     Text format    


    April 2018
  42. MI MY, Block PC, Broderick JP
    PFO Closure for Cryptogenic Stroke.
    N Engl J Med. 2018;378:1639-1642.
    PubMed     Text format    


  43. CAMPBELL BCV, Mitchell PJ, Churilov L, Yassi N, et al
    Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    N Engl J Med. 2018;378:1573-1582.
    PubMed     Text format     Abstract available


  44. BAIRD AE
    Paving the Way for Improved Treatment of Acute Stroke with Tenecteplase.
    N Engl J Med. 2018;378:1635-1636.
    PubMed     Text format    


  45. MORITA H, Komuro I
    Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
    N Engl J Med. 2018;378:1561.
    PubMed     Text format    


  46. NIKOLAEV SI, Fish JE, Radovanovic I
    Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
    N Engl J Med. 2018;378:1561-1562.
    PubMed     Text format    


  47. ANDERSON CS, Woodward M, Chalmers J
    More on Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.
    N Engl J Med. 2018;378:1465-1466.
    PubMed     Text format    


    March 2018
  48. VINNY PW, Vishnu VY, Padma Srivastava MV
    Thrombectomy 6 to 24 Hours after Stroke.
    N Engl J Med. 2018;378:1161.
    PubMed     Text format    


  49. JOVIN TG, Nogueira RG
    Thrombectomy 6 to 24 Hours after Stroke.
    N Engl J Med. 2018;378:1161-1162.
    PubMed     Text format    


  50. MEHRA MR, Goldstein DJ, Uriel N, Cleveland JC Jr., et al
    Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure.
    N Engl J Med. 2018 Mar 11. doi: 10.1056/NEJMoa1800866.
    PubMed     Text format     Abstract available


  51. CAMARGO EC, Huang SY, Karaa A, Rosenbaum MW, et al
    Case 7-2018: A 25-Year-Old Man with New-Onset Seizures.
    N Engl J Med. 2018;378:941-948.
    PubMed     Text format    


    February 2018
  52. BAUASHVILI A, Evans AT
    Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    N Engl J Med. 2018;378:485.
    PubMed     Text format    


  53. DEKKERS T, Lafeber M, Kramers C
    Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    N Engl J Med. 2018;378:484-5.
    PubMed     Text format    


  54. WANG X, Karnieg T
    Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    N Engl J Med. 2018;378:484.
    PubMed     Text format    



  55. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    N Engl J Med. 2018;378:484-486.
    PubMed     Text format    


  56. PICCINI JP, Jones WS
    Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    N Engl J Med. 2018;378:486.
    PubMed     Text format    


    January 2018
  57. ALBERS GW, Marks MP, Kemp S, Christensen S, et al
    Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.
    N Engl J Med. 2018 Jan 24. doi: 10.1056/NEJMoa1713973.
    PubMed     Text format     Abstract available


  58. NIKOLAEV SI, Vetiska S, Bonilla X, Boudreau E, et al
    Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
    N Engl J Med. 2018;378:250-261.
    PubMed     Text format     Abstract available


  59. ZHENG MX, Hua XY, Feng JT, Li T, et al
    Trial of Contralateral Seventh Cervical Nerve Transfer for Spastic Arm Paralysis.
    N Engl J Med. 2018;378:22-34.
    PubMed     Text format     Abstract available


    December 2017
  60. BRAEMSWIG TB, Scheitz JF, Nolte CH
    Trials of Patent Foramen Ovale Closure.
    N Engl J Med. 2017;377:2599.
    PubMed     Text format    


  61. COSMI D, Mariottoni B, Cosmi F
    Trials of Patent Foramen Ovale Closure.
    N Engl J Med. 2017;377:2598-2599.
    PubMed     Text format    


  62. MAS JL, Derumeaux G, Chatellier G
    Trials of Patent Foramen Ovale Closure.
    N Engl J Med. 2017;377:2599-2600.
    PubMed     Text format    


  63. CUCULICH PS, Schill MR, Kashani R, Mutic S, et al
    Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia.
    N Engl J Med. 2017;377:2325-2336.
    PubMed     Text format     Abstract available


  64. KELLY NP, Gerhard-Herman M, Desai AS, Miller AL, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:2267-2272.
    PubMed     Text format    


    November 2017
  65. KELLY NP, Vaidya A, Gerhard-Herman M, Desai AS, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:e29.
    PubMed     Text format    


  66. MAZER CD, Whitlock RP, Fergusson DA, Hall J, et al
    Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery.
    N Engl J Med. 2017 Nov 12. doi: 10.1056/NEJMoa1711818.
    PubMed     Text format     Abstract available


  67. NOGUEIRA RG, Jadhav AP, Haussen DC, Bonafe A, et al
    Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.
    N Engl J Med. 2017 Nov 11. doi: 10.1056/NEJMoa1706442.
    PubMed     Text format     Abstract available


  68. HACKE W
    A New DAWN for Imaging-Based Selection in the Treatment of Acute Stroke.
    N Engl J Med. 2017 Nov 11. doi: 10.1056/NEJMe1713367.
    PubMed     Text format    


  69. GOLDSTONE AB, Chiu P, Baiocchi M, Lingala B, et al
    Mechanical or Biologic Prostheses for Aortic-Valve and Mitral-Valve Replacement.
    N Engl J Med. 2017;377:1847-1857.
    PubMed     Text format     Abstract available


    October 2017
  70. AKIYAMA M
    Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1493-4.
    PubMed     Text format    


  71. GONZALES-GAY MA, Loricera J, Blanco R
    Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1493.
    PubMed     Text format    


  72. STONE JH, Klearman M, Collinson N
    Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1494-1495.
    PubMed     Text format    



  73. Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1493.
    PubMed     Text format    


    September 2017
  74. RIDKER PM, Everett BM, Thuren T, MacFadyen JG, et al
    Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
    N Engl J Med. 2017;377:1119-1131.
    PubMed     Text format     Abstract available


  75. SIBON I, Gerardin P, Gauthier A
    Head Positioning in Acute Stroke.
    N Engl J Med. 2017;377:1101.
    PubMed     Text format    


  76. FELDMAN WB, Chiong W, Kim SYH
    Head Positioning in Acute Stroke.
    N Engl J Med. 2017;377:1101-2.
    PubMed     Text format    


  77. FARB A, Ibrahim NG, Zuckerman BD
    Patent Foramen Ovale after Cryptogenic Stroke - Assessing the Evidence for Closure.
    N Engl J Med. 2017;377:1006-1009.
    PubMed     Text format    


  78. MAS JL, Derumeaux G, Guillon B, Massardier E, et al
    Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
    N Engl J Med. 2017;377:1011-1021.
    PubMed     Text format     Abstract available


  79. SAVER JL, Carroll JD, Thaler DE, Smalling RW, et al
    Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.
    N Engl J Med. 2017;377:1022-1032.
    PubMed     Text format     Abstract available


  80. TAITO S, Yamauchi K
    Head Positioning in Acute Stroke.
    N Engl J Med. 2017;377:1102.
    PubMed     Text format    



  81. Head Positioning in Acute Stroke.
    N Engl J Med. 2017;377:1102-3.
    PubMed     Text format    


  82. SONDERGAARD L, Kasner SE, Rhodes JF, Andersen G, et al
    Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
    N Engl J Med. 2017;377:1033-1042.
    PubMed     Text format     Abstract available


  83. ROPPER AH
    Tipping Point for Patent Foramen Ovale Closure.
    N Engl J Med. 2017;377:1093-1095.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Cerebrovascular Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: